| Literature DB >> 31016089 |
Susan Rajan1, Anandhi Amaranathan1, Subitha Lakshminarayanan2, Sathasivam Sureshkumar1, Manoj Joseph3, Vishnu Prasad Nelamangala Ramakrishnaiah1.
Abstract
Introduction Extensive use of upper gastrointestinal endoscopy (UGE) with the advent of open access centers has resulted in inappropriate endoscopies. Our study aimed to evaluate the appropriateness of American Society for Gastrointestinal Endoscopy (ASGE) guidelines for UGE and to assess the diagnostic yield of endoscopy in a tertiary care center in South India. Methods The study was conducted as a prospective analytical study. Indications for endoscopy were classified as "ASGE appropriate" and "ASGE inappropriate". The significance of association of ASGE guidelines and other categorical variables with endoscopic findings were assessed. Results ASGE appropriate indications and inappropriate indications accounted for 85.9% and 14.1% of endoscopies, respectively. The most common appropriate indication was persistent dyspepsia despite adequate proton-pump inhibitor (PPI) therapy (28.1%) and the only inappropriate indication for endoscopy was isolated dyspepsia without adequate PPI therapy (14.1%). The diagnostic yield of endoscopy for appropriate indications was 69.5% and for inappropriate indications was 55.1%, the difference was statistically significant (P= 0.003; OR-1.857). The sensitivity and specificity of ASGE guidelines was 88.5% and 19.5%, respectively. Conclusion According to our study, ASGE guidelines may be considered as appropriate guidelines for UGE in our population and these guidelines were followed 85.9% of the times in referring patients for the same. However, the high diagnostic yield even in inappropriate endoscopies indicates the necessity of further studies that might identify other relevant indications for endoscopy, thus avoiding misutilization of resources without missing out on relevant cases.Entities:
Keywords: appropriateness of endoscopies; asge guidelines; indications for endoscopies; upper gastrointestinal endoscopy
Year: 2019 PMID: 31016089 PMCID: PMC6464286 DOI: 10.7759/cureus.4062
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Association of baseline and clinical characteristics of the study subjects with positive endoscopic findings
*Chi-Square Test; 95% CI – 95% Confidence Interval; NSAID – Non-Steroidal Anti-Inflammatory Drugs; BMI – Body Mass Index
| S. No. | Study Characteristics | Overall % (N=757) | Positive Endoscopic Finding % (N = 511) | Odds Ratio (95% CI) | P-value* | |
| 1. | Age | >50 years | 43.3 | 71.0 | 1.332 (0.977-1.817) | 0.070 |
| ≤49 years | 56.7 | 64.8 | - | |||
| 2. | Gender | Male | 57.2 | 72.5 | 1.701 (1.251-2.312) | 0.001 |
| Female | 42.8 | 60.8 | - | |||
| 3. | Comorbidities | Present | 18.8 | 64.1 | 0.808 (0.565-1.215) | 0.335 |
| Absent | 81.2 | 68.3 | - | |||
| 4. | NSAID or another drug use | Present | 4.5 | 58.8 | 0.675 (0.335-1.360) | 0.269 |
| Absent | 95.5 | 67.9 | - | |||
| 5. | Tobacco use | Present | 40.2 | 73.7 | 1.620 (1.177-2.228) - | 0.003 |
| Absent | 59.8 | 63.4 | ||||
| 6. | Alcohol use | Present | 49.5 | 73.9 | 1.788 (1.313-2.435) | <0.001 |
| Absent | 50.5 | 61.3 | - | |||
| 7. | BMI | Underweight | 7.5 | 78.9 | 1.740 (0.771-3.927) | 0.183 |
| Overweight & obese | 45.7 | 61.8 | 0.656 (0.420-1.027) | 0.065 | ||
| Normal | 44.9 | 71.5 | - | - | ||
Association of the ASGE guidelines with positive endoscopic findings (n = 757)
*Chi-Square Test; 95% CI – 95% Confidence Interval; ASGE – American Society for Gastrointestinal Endoscopy
| S. No. | ASGE Guidelines | Overall % (N=757) | Positive Endoscopic Finding % (N=511) | Odds Ratio (95% CI) | P-value* |
| 1. | Appropriate | 85.9 | 452 (69.5%) | 1.857 (1.25-2.815) | 0.003 |
| 2. | Inappropriate | 14.1 | 59 (55.1%) | - |
Indications for endoscopy and its association with positive endoscopic finding (n=757)
*Chi-Square Test; 95% CI – 95% Confidence Interval; ASGE – American Society for Gastrointestinal Endoscopy; PPI – Proton-Pump Inhibitor; GI – Gastrointestinal; 2.1% of ASGE appropriate indications were for other indications like poisoning, foreign body ingestion, etc.
| S. No. | Indications for Endoscopy | Overall % (N=757) | Positive Endoscopic Finding% (N=511) | Odds Ratio (95% CI) | P-value* |
| I | ASGE appropriate indications | ||||
| 1 | Persistent dyspepsia despite adequate PPI therapy | 28.1 | 62.9 | 0.751 (0.539-1.048) | 0.091 |
| 2 | Age >50 years with new onset upper abdominal symptoms and signs | 16.6 | 56.3 | 0.560 (0.379-0.828) | 0.003 |
| 3 | GI bleeding or anemia | 18.1 | 82.5 | 2.626 (1.641-4.202) | <0.001 |
| 4 | Progressive dysphagia & odynophagia | 12.5 | 81.1 | 2.247 (1.313-3.847) | 0.003 |
| 5 | Persistent vomiting | 6.6 | 84.0 | 2.664 (1.231-5.765) | 0.010 |
| 6 | Unintended weight loss | 1.6 | 83.3 | 2.435 (0.529-11.200) | 0.238 |
| 7 | Family history of upper GI malignancy | 0.3 | 50.0 | 0.480 (0.030-7.712) | 0.545 |
| II | ASGE inappropriate indications | ||||
| 1 | Isolated dyspepsia without adequate PPI therapy | 14.1 | 55.1 | 0.538 (0.355-0.816) | 0.003 |
Endoscopic findings according to the appropriateness of the indication (n=757)
*Chi-Square Test; 95% CI – 95% Confidence Interval
| S. No. | Endoscopic Finding | Appropriate Indication N (%) | Inappropriate Indication N (%) | Odds Ratio (95% CI) | P-value* |
| 1 | Erosions | 240 (84.8%) | 43 (15.2%) | 0.871 (0.574-1.323) | 0.520 |
| 2 | Ulcer | 51 (91.1%) | 5 (5%) | 1.737 (0.677-4.456) | 0.245 |
| 3 | Varices | 34 (97.1%) | 1 (2.9%) | 5.851 (0.792-43.197) | 0.050 |
| 4 | Mass lesions | 88 (96.7%) | 3 (3.3%) | 5.428 (1.685-17.482) | 0.002 |
| 5 | Stricture | 7 (77.8%) | 2 (22.2%) | 0.572 (0.117-2.789) | 0.371 |
Sensitivity, specificity, and predictive values of ASGE guidelines in the current study (n=757)
*NPV – Negative Predictive Value; PPV – Positive Predictive Value; ASGE – American Society for Gastrointestinal Endoscopy; PPI – Proton-Pump Inhibitor; GI – Gastrointestinal
| S. No. | Indications | Sensitivity | Specificity | PPV | NPV |
| 1 | ASGE guidelines | 88.5% | 19.5% | 69.5% | 44.9% |
| 2 | Persistent dyspepsia despite adequate PPI therapy | 26.2% | 67.9% | 62.9% | 30.7% |
| 3 | Age more than 50 years with new onset symptoms or upper abdominal symptoms or signs indicating structural disease | 13.9% | 77.6% | 56.3% | 30.3% |
| 4 | GI bleeding or anemia | 22.1% | 90.2% | 82.5% | 35.8% |
| 5 | Progressive dysphagia or odynophagia | 15.1% | 92.7% | 81.1% | 34.4% |
| 6 | Persistent vomiting | 8.2% | 96.7% | 84.0% | 33.7% |
| 7 | Unintended weight loss | 2% | 99.2% | 83.3% | 32.8% |
| 8 | Isolated dyspepsia without adequate PPI therapy | 11.5% | 80.5% | 55.1% | 30.5% |
Multivariate analysis of indications and clinical parameters with endoscopy (n=757)
*OR – Odds Ratio; 95% CI – 95% Confidence Interval; ASGE – American Society for Gastrointestinal Endoscopy
| S. No. | Clinical Parameters and Indications | Adjusted OR (95% CI) | P-value |
| 1 | Age> 50 years | 1.059 (0.755-1.485) | 0.740 |
| 2 | Male gender | 1.223 (0.756-1.978) | 0.413 |
| 3 | Alcohol use | 1.364 (0.824-2.257) | 0.227 |
| 4 | Tobacco use | 1.222 (0.839-1.781) | 0.296 |
| 5 | ASGE Indications | 1.753 (1.128-2.725) | 0.013 |